| Entry |
|
|---|
| Name |
Penciclovir (USAN/INN);
Denavir (TN)
|
|---|
| Product |
|
|---|
| Formula |
C10H15N5O3
|
|---|
| Exact mass |
253.1175
|
|---|
| Mol weight |
253.2578
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BB Antivirals
D06BB06 Penciclovir
D05407 Penciclovir (USAN/INN)
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB13 Penciclovir
D05407 Penciclovir (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Antiherpetic Agents
Penciclovir
D05407 Penciclovir (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-HSV agent
DNA polymerase inhibitor
Purine analogue
Penciclovir [ATC:D06BB06 J05AB13]
D05407 Penciclovir (USAN/INN)
 |
|---|
| Other DBs |
CAS: 39809-25-1 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 18
1 C8y C 24.9139 -15.2988
2 C8y C 24.9480 -13.8956
3 N4y N 23.5764 -15.6994
4 N4x N 26.1134 -16.0242
5 N5x N 23.6252 -13.4366
6 C8y C 26.1810 -13.2292
7 C8x C 22.7793 -14.5511
8 C8y C 27.3406 -15.3575
9 N5x N 27.3745 -13.9543
10 O5x O 26.1507 -11.8319
11 N1a N 28.5341 -16.0828
12 C1b C 23.5764 -17.0994
13 C1b C 22.3825 -17.7885
14 C1c C 21.1797 -17.0938
15 C1b C 19.9959 -17.7770
16 C1b C 21.1797 -15.6803
17 O1a O 19.9900 -14.9932
18 O1a O 18.8030 -17.0879
BOND 19
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 1
8 6 9 1
9 6 10 2
10 8 11 1
11 5 7 2
12 8 9 2
13 3 12 1
14 12 13 1
15 13 14 1
16 14 15 1
17 14 16 1
18 16 17 1
19 15 18 1
|
|---|
